Vancomycin Dosing for Continuous Renal Replacement Therapy
For adult patients on CRRT, initiate vancomycin with a loading dose of 25-30 mg/kg (based on actual body weight), followed by maintenance dosing of 5-7.5 mg/kg every 12 hours, adjusted based on CRRT intensity (effluent flow rate), with mandatory therapeutic drug monitoring targeting trough concentrations of 15-20 mg/L or AUC₂₄/MIC ≥400.
Initial Loading Dose
Start with a loading dose of 25-30 mg/kg based on actual body weight 1, 2. This aggressive loading is critical because:
- CRRT significantly increases vancomycin clearance, with CRRT accounting for >50% of total drug clearance 3
- Standard dosing (15 mg/kg) consistently fails to achieve therapeutic targets in CRRT patients 4, 5
- At higher CRRT intensities (effluent rates >30 mL/kg/h), loading doses up to 35 mg/kg may be necessary 2
The FDA label recommends an initial dose of at least 15 mg/kg even in renal impairment 6, but this is insufficient for CRRT patients based on contemporary pharmacokinetic data.
Maintenance Dosing Strategy
Effluent-Adjusted Regimens
Your maintenance dose must be titrated to CRRT intensity:
- Low-intensity CRRT (20-25 mL/kg/h effluent rate): 5 mg/kg every 12 hours 1
- Moderate-intensity CRRT (25-45 mL/kg/h effluent rate): 7.5 mg/kg every 12 hours 1
- High-intensity CRRT (>30 mL/kg/h or >3 L/h): ≥15 mg/kg/day, potentially up to 27 mg/kg/day in divided doses 5
The effluent flow rate is the single most important determinant of vancomycin clearance during CRRT 2, 3. As dialysate flow rate increases, there is an inverse relationship with vancomycin serum concentrations 5.
Dosing Frequency Considerations
Administer maintenance doses every 12 hours rather than daily 1. While total daily AUC remains similar, more frequent dosing helps maintain steadier trough concentrations and reduces the risk of subtherapeutic periods between doses.
Therapeutic Targets and Monitoring
Target Concentrations
Aim for trough concentrations of 15-20 mg/L for serious infections (bacteremia, endocarditis, osteomyelitis, pneumonia) 7. This corresponds to an AUC₂₄/MIC ratio ≥400 (assuming MIC ≤1 mg/L) 1, 4.
Critical finding: Recent data in CRRT patients identified an AUC threshold of 427 mg·h/L as the optimal efficacy target 1, which is lower than traditional targets but reflects the unique pharmacokinetics in this population.
Monitoring Schedule
- Obtain the first vancomycin level within 24 hours of initiating therapy 8
- Measure trough concentrations just before the fourth dose for patients on prolonged therapy 7
- Check levels more frequently (every 24-48 hours) in CRRT patients due to high pharmacokinetic variability 2, 3
- Use AUC-based monitoring when available, as AUC is a better predictor of both efficacy and nephrotoxicity than trough alone 5, 9
Administration Guidelines
Infuse vancomycin at ≤10 mg/min or over at least 60 minutes, whichever is longer 6. For doses exceeding 1 gram, extend infusion time to 1.5-2 hours 7. This reduces infusion-related reactions.
Key Covariates Affecting Dosing
Beyond effluent rate, adjust for:
- Residual kidney function: Any preserved diuresis reduces vancomycin requirements 2, 3
- Albumin concentration: Hypoalbuminemia increases free drug fraction 2
- Vasopressor use: Hemodynamic instability alters volume of distribution 2
- Body weight: Use actual body weight for dosing calculations 7
Critical Pitfalls to Avoid
Do not use standard renal dosing tables for CRRT patients—these are invalid for functionally anephric patients on dialysis 6
Do not rely on fixed nomograms—vancomycin clearance during CRRT ranges from 1.5-4.8 L/h with massive interindividual variability 3
Do not target troughs <10 mg/L—this promotes resistance development 7
Do not skip loading doses—underdosing in the first 24-48 hours is associated with treatment failure 4
Do not assume therapeutic levels are achieved—only 54% of patients on traditional dosing (15 mg/kg/day) reach target AUC₂₄/MIC ≥400, compared to 74% with enhanced dosing (≥15 mg/kg/day) 5
Nephrotoxicity Monitoring
Monitor serum creatinine closely, though this is challenging in CRRT patients. Vancomycin-induced nephrotoxicity is defined as 2-3 consecutive creatinine increases of ≥0.5 mg/dL or ≥50% from baseline 7. AUC values >700 mg·h/L increase nephrotoxicity risk 4, though the FDA label notes limited direct causal data 6.
Pre-existing renal function (pre-treatment creatinine clearance) is the primary predictor of post-treatment renal outcomes 9.